Medical Technology - Algeria

  • Algeria
  • The revenue in the Medical Technology market market in Algeria is expected to reach US$1.66bn by 2024.
  • The largest market within this industry is Medical Devices, which is projected to have a market volume of US$1.39bn in 2024.
  • The revenue is anticipated to grow at an annual growth rate of 3.48% (CAGR 2024-2029), resulting in a market volume of US$1.97bn by 2029.
  • In comparison to other countries, the United States is projected to generate the highest revenue, amounting to US$211.10bn in 2024.
  • Algeria's medical technology market is experiencing a surge in demand for advanced diagnostic equipment to improve healthcare outcomes.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Algeria is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trend. Customer preferences in Algeria are shifting towards advanced medical technology. Algerian consumers are becoming more aware of the benefits of innovative medical devices and are demanding access to cutting-edge technology. This shift is driven by factors such as increasing disposable income, improved healthcare infrastructure, and a growing middle class. Patients are seeking more accurate diagnoses, minimally invasive procedures, and faster recovery times, which can be achieved with the help of advanced medical technology. Trends in the market reflect the global advancements in medical technology. Algeria is witnessing a rise in demand for telemedicine solutions, remote patient monitoring devices, and wearable health technology. These trends are driven by the need to improve access to healthcare services in remote areas, reduce healthcare costs, and enhance patient convenience. Additionally, there is a growing demand for medical imaging devices, such as MRI and CT scanners, as well as surgical robots, which enable precise and efficient procedures. Local special circumstances in Algeria also contribute to the development of the Medical Technology market. The government has been actively investing in the healthcare sector, aiming to improve healthcare outcomes and reduce the burden on the public healthcare system. This investment includes the construction of new hospitals and clinics, the expansion of existing healthcare facilities, and the implementation of digital health initiatives. These efforts create a favorable environment for the adoption of medical technology and attract international companies to invest in the Algerian market. Underlying macroeconomic factors further support the growth of the Medical Technology market in Algeria. The country's economy has been growing steadily, driven by sectors such as oil and gas, construction, and manufacturing. This economic growth translates into increased healthcare spending and a greater ability to invest in advanced medical technology. Additionally, the government's focus on diversifying the economy and reducing dependence on oil revenues creates opportunities for the development of the healthcare sector, including the Medical Technology market. In conclusion, the Medical Technology market in Algeria is developing due to customer preferences for advanced technology, global trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for innovative medical devices and technology is on the rise, driven by factors such as improved healthcare infrastructure, increasing disposable income, and a growing middle class. The government's investment in the healthcare sector, coupled with the country's economic growth, further supports the development of the Medical Technology market in Algeria.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)